biootje schreef op 1 juli 2014 21:39:
lees ook dit:
Salix is vandaag met 13 % gestegen
De vraag werd gesteld vanwaar die stijging
Het antwoord is hier te lezen:
www.fool.com/investing/general/2014/0..."Now what: In addition to this positive news, Salix also has a big catalyst coming up in two weeks involving the Food and Drug Administration's decision on ruconest, a hereditary angioedema drug that it acquired when it purchased Santarus for $2.6 billion in cash. Chances are probably better than 50-50 that it will be approved as well (at least in my opinion)."
De stijging van Pharming vandaag is nog maar het begin